BALAXI PHARMACEUTICALS LIMITED (BALAXI) — Capital Reinvestment Ratio
Latest as of September 2025:
0.83x
BALAXI PHARMACEUTICALS LIMITED (BALAXI) has a Capital Reinvestment Ratio of 0.83x as of September 2025, meaning it reinvests 1% of its operating cash flow (Rs149.66 Million) in capital expenditures (Rs123.88 Million). See BALAXI free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.83x
Capex / Operating Cash Flow
Operating Cash Flow
Rs149.66 Million
INR
Capital Expenditures
Rs123.88 Million
INR
Data as of
Sep 2025
Most recent filing
BALAXI PHARMACEUTICALS LIMITED Capital Reinvestment Ratio (2015–2024)
This chart tracks BALAXI PHARMACEUTICALS LIMITED's Capital Reinvestment Ratio across 5 annual periods.
Annual Capital Reinvestment Ratio for BALAXI PHARMACEUTICALS LIMITED (2015–2024)
Year-by-year Capital Reinvestment Ratio for BALAXI PHARMACEUTICALS LIMITED from 2015 to 2024. For live market cap and broader valuation context, see BALAXI market cap.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.32x | Rs48.66 Million | Rs15.69 Million | ▼ -86.9% |
| 2023 | 2.47x | Rs60.75 Million | Rs149.80 Million | ▲ +207.9% |
| 2022 | 0.80x | Rs341.44 Million | Rs273.44 Million | ▼ -99.9% |
| 2021 | 824.65x | Rs31.00K | Rs25.56 Million | ▲ +5861379.5% |
| 2015 | 0.01x | Rs2.11 Million | Rs29.72K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow